Biopsy-Confirmed Small Vessel Primary CNS Vasculitis
This study highlights the considerable clinical heterogeneity in sv-PCNSV, a rare but serious condition. Early, aggressive treatment with cyclophosphamide is associated with a shorter time to remission, and further validation in prospective studies is warranted.
Authors
- Sharon A. Chung (ORCID: https://orcid.org/0000-0002-2238-2287)
- Jeffrey Marc Gelfand (ORCID: https://orcid.org/0000-0002-5121-3319)
- Sarah Goglin (ORCID: https://orcid.org/0000-0002-6239-6210)
- Shane T. Poole (ORCID: https://orcid.org/0000-0002-3203-151X)
- Riley M. Bove (ORCID: https://orcid.org/0000-0002-2034-8800)
- Tarık Tihan (ORCID: https://orcid.org/0000-0003-4551-2555)
- Melike Pekmezci (ORCID: https://orcid.org/0000-0003-2548-8359)
- Sumanth Reddy (ORCID: https://orcid.org/0000-0002-6275-6001)
- Sara C. LaHue (ORCID: https://orcid.org/0000-0003-2396-7663)
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1212/nxi.0000000000200397
- Citations
- 3
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 4.56